Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,179 Cr
up ₹156 Cr vs Dec 2023
- Stocks held
- 27
- up 1 vs Dec 2023
- Top 10 weight
- 69.2%
- of the portfolio in its ten largest
- Cash & debt
- 0.9%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 9
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In January 2024 it disclosed 27 stocks worth ₹2,179 Cr, up ₹156 Cr from Dec 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.3%), Suven Pharmaceuticals Limited (8.1%), IPCA Laboratories Limited (8.0%); the ten largest together made up 69.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 71.1% of its equity. Cash and debt stood at 0.9%. Compared with Dec 2023 the fund entered 1 new stock and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
11%
Holds more stocks than 11% of peers
Cash
11%
Holds more cash than 11% of peers
What these mean: concentration · cash
Holdings in January 2024
Download CSVEvery line the fund disclosed, with the change against Dec 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.27% | up 0.58 pts | ₹289 Cr | up ₹32.4 Cr | Added |
| Suven Pharmaceuticals Limited | 8.06% | down 0.91 pts | ₹176 Cr | down ₹5.8 Cr | Trimmed |
| IPCA Laboratories Limited | 8.00% | down 0.40 pts | ₹174 Cr | up ₹4.4 Cr | Added |
| Cipla Limited | 7.96% | up 0.05 pts | ₹173 Cr | up ₹13.4 Cr | Added |
| Lupin Limited | 7.55% | up 0.40 pts | ₹164 Cr | up ₹19.9 Cr | Added |
| Alembic Pharmaceuticals Limited | 5.95% | up 0.88 pts | ₹130 Cr | up ₹27.1 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.43% | up 0.18 pts | ₹118 Cr | up ₹12.1 Cr | Added |
| Globus Medical Inc | 4.47% | down 0.39 pts | ₹97.4 Cr | down ₹97 L | Trimmed |
| Alkem Laboratories Limited | 4.30% | down 0.52 pts | ₹93.7 Cr | down ₹3.9 Cr | Trimmed |
| Concord Biotech Limited | 4.17% | down 0.37 pts | ₹90.9 Cr | down ₹99 L | Trimmed |
| Procter & Gamble Health Limited | 3.74% | down 0.14 pts | ₹81.5 Cr | up ₹2.9 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.09% | down 0.31 pts | ₹67.3 Cr | down ₹1.6 Cr | Trimmed |
| Indoco Remedies Limited | 2.89% | up 0.18 pts | ₹63 Cr | up ₹8.2 Cr | Added |
| Zydus Lifesciences Limited | 2.89% | up 0.07 pts | ₹62.9 Cr | up ₹5.9 Cr | Added |
| Intuitive Surgical Inc | 2.71% | up 0.11 pts | ₹59 Cr | up ₹6.3 Cr | Added |
| Kovai Medical Center and Hospital Limited | 2.44% | up 0.68 pts | ₹53.1 Cr | up ₹17.5 Cr | Added |
| Aarti Drugs Limited | 1.78% | down <0.01 pts | ₹38.8 Cr | up ₹2.8 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 1.66% | down 0.04 pts | ₹36.1 Cr | up ₹1.9 Cr | Added |
| Unichem Laboratories Limited | 1.58% | up 0.10 pts | ₹34.4 Cr | up ₹4.6 Cr | Added |
| Taro Pharmaceutical Industries Limited | 1.47% | down 0.07 pts | ₹32 Cr | up ₹93 L | Added |
| Abbott Laboratories | 1.36% | down 0.07 pts | ₹29.7 Cr | up ₹79 L | Added |
| Illumina Inc | 1.11% | down 0.05 pts | ₹24.2 Cr | up ₹63 L | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.06% | down 0.17 pts | ₹23.1 Cr | down ₹1.8 Cr | Trimmed |
| Cash, TREPS & receivables | 0.92% | up 0.06 pts | ₹20 Cr | up ₹2.7 Cr | Added |
| MedPlus Health Services Limited | 0.63% | down 0.08 pts | ₹13.8 Cr | down ₹66 L | Trimmed |
| Narayana Hrudayalaya Limited | 0.52% | up 0.52 pts | ₹11.2 Cr | up ₹11.2 Cr | New |
| Jupiter Life Line Hospitals Limited | 0.47% | down 0.05 pts | ₹10.3 Cr | down ₹25 L | Trimmed |
| Pfizer Limited | 0.30% | down 0.02 pts | ₹6.6 Cr | up ₹8 L | Added |
| Mankind Pharma Limited | 0.22% | down 0.22 pts | ₹4.8 Cr | down ₹4.1 Cr | Trimmed |
What changed, Dec 2023 to Jan 2024
New New positions (1)
- Narayana Hrudayalaya Limited0.5% · ₹11.2 Cr
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹32.4 Cr (+0.58% pts)
- Alembic Pharmaceuticals Limitedup ₹27.1 Cr (+0.88% pts)
- Lupin Limitedup ₹19.9 Cr (+0.40% pts)
- Kovai Medical Center and Hospital Limitedup ₹17.5 Cr (+0.68% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2023, the weight rose most in Healthcare Services (+1.0 pts) and Pharmaceuticals (+0.2 pts), and fell most in Pharmaceuticals & Biotechnology (−0.8 pts) and Healthcare Equipment & Supplies (−0.3 pts).
- Healthcare Services12.4% → 13.3%+1.0 pts
- Pharmaceuticals5.7% → 6.0%+0.2 pts
- Pharmaceuticals & Biotechnology71.8% → 71.1%−0.8 pts
- Healthcare Equipment & Supplies7.6% → 7.3%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2021 | Jan 2023 | Jul 2023 | Oct 2023 | Dec 2023 | Jan 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.4% | 67.6% | 72.4% | 73.3% | 71.8% | 71.1% |
| Healthcare Services | 21.1% | 16.6% | 12.8% | 11.7% | 12.4% | 13.3% |
| Healthcare Equipment & Supplies | 3.3% | 6.6% | 5.7% | 6.3% | 7.6% | 7.3% |
| Pharmaceuticals | 7.1% | 5.8% | 5.6% | 5.8% | 5.7% | 6.0% |
| Insurance | 3.1% | 2.3% | 2.3% | 2.0% | 1.7% | 1.7% |
| Retailing | — | 1.0% | 1.3% | 0.9% | 0.7% | 0.6% |
Allocation in Jan 2024change vs Dec 2023
- Pharmaceuticals & Biotechnology (14)71.1%▼ 0.8 pts
- Healthcare Services (6)13.3%▲ 1.0 pts
- Healthcare Equipment & Supplies (2)7.3%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2024
0.9%
▲ 0.1 pts vs Dec 2023
- Cash alone
- 0.9%
- cash and net receivables
- A year earlier
- 2.6%
- Jan 2023 · now ▼ 1.7 pts
- Last 12 months
- <0.1% – 3.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.